• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

agamatrix

Dexcom claims win in patent war with AgaMatrix unit WaveForm

August 26, 2019 By Brad Perriello

Dexcom, AgaMatrix

Dexcom Inc. (NSDQ:DXCM) last week claimed a win along one front of its patent war with AgaMatrix subsidiary WaveForm Technologies, when an Oregon federal court dismissed a lawsuit alleging that its continuous glucose monitors infringe WaveForm patents. Wilsonville, Ore.-based WaveForm sued Dexcom in March 2016, alleging infringement of a trio of patents covering a compound […]

Filed Under: Diabetes, Featured, Legal News Tagged With: agamatrix, DexCom Inc., waveformtechnologies

AgaMatrix raises $56m for WaveForm CGM

July 3, 2019 By Brad Perriello

AgaMatrix

AgaMatrix said today that it brought in a $56 million funding round for the eponymous continuous glucose monitor its WaveForm Technologies subsidiary is developing. The round, which includes $6 million from new and existing backers and $50 million in senior debt financing from Perceptive Advisors, is slated for paying down debt and increasing production capacity, […]

Filed Under: Diabetes, Featured, Funding Roundup, Wall Street Beat Tagged With: agamatrix, waveformtechnologies

Dexcom hit with legal fees in AgaMatrix patent spat

May 24, 2018 By Fink Densford

gavel

Dexcom (NSDQ:DXCM) this week was ordered to pay attorney’s fees in a spat with rival AgaMatrix over patents related to continuous glucose monitoring technology. The ruling came alongside a final judgement of non-infringement in favor of AgaMatrix from Judge S. James Otero of the US District Court for the Central District of California Western Division, according […]

Filed Under: Diabetes, Featured, Legal News Tagged With: agamatrix, DexCom Inc.

Patent board upholds AgaMatrix’s CGM patents in Dexcom IP spat

March 6, 2018 By Sarah Faulkner

gavel

The legal back and forth between Dexcom (NSDQ:DXCM) and AgaMatrix over the companies’ continuous glucose monitoring IP dates back to March of 2016, when AgaMatrix launched a patent infringement lawsuit against the San Diego, Calif.-based manufacturer in the U.S. District Court of Oregon. Later that year, Dexcom filed for inter parters review with the Patent Trial […]

Filed Under: Diabetes, Featured, Legal News, Wall Street Beat Tagged With: agamatrix, DexCom Inc., waveformtechnologies

Dexcom beats The Street with Q4 sales, earnings

February 28, 2018 By Sarah Faulkner

Dexcom

Dexcom (NSDQ:DXCM) beat expectations on Wall Street with its fourth quarter and full year financial results, growing its quarterly revenue 29% compared to the same period last year. The San Diego, Calif.-based company posted a net loss of -$9.4 million, or -11¢ per share, on sales of $221 million for the 3 months ended Dec. 31. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: agamatrix, DexCom Inc.

AgaMatrix lands $32m loan for split

October 6, 2017 By Sarah Faulkner

AgaMatrix

With a $32 million loan in hand, AgaMatrix said this week it plans to reorganize the companies into two entities – AgaMatrix, Inc. and WaveForm Technologies. The holding company raised $32 million from Prospect Capital Corp. and said it will use the funds to support sales and marketing, product development and clinical trial activities for its […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: agamatrix

Glytec, AgaMatrix ink deal to develop digital diabetes management platform

June 9, 2017 By Sarah Faulkner

AgaMatrix, Glytec

AgaMatrix and Glytec said today that the companies are partnering to develop a cloud-based diabetes management platform to optimize clinical access to glucose data and insulin titration support. The platform will combine AgaMatrix’s FDA-cleared Jazz Wireless 2 Bluetooth blood glucose monitoring tech with Glytec’s eGlycemic Management System, according to the companies. The companies are developing […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: agamatrix, Glytec

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS